Elevance Health, Inc. $ELV Position Increased by Greatmark Investment Partners Inc.

Greatmark Investment Partners Inc. lifted its holdings in Elevance Health, Inc. (NYSE:ELV) by 23.8% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 35,483 shares of the company’s stock after buying an additional 6,833 shares during the quarter. Elevance Health makes up 1.4% of Greatmark Investment Partners Inc.’s portfolio, making the stock its 24th biggest position. Greatmark Investment Partners Inc.’s holdings in Elevance Health were worth $11,465,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of ELV. Vermillion & White Wealth Management Group LLC lifted its holdings in Elevance Health by 94.9% in the second quarter. Vermillion & White Wealth Management Group LLC now owns 76 shares of the company’s stock worth $30,000 after acquiring an additional 37 shares during the last quarter. BOK Financial Private Wealth Inc. acquired a new stake in shares of Elevance Health during the 2nd quarter worth approximately $32,000. Motco lifted its holdings in shares of Elevance Health by 334.8% in the 3rd quarter. Motco now owns 100 shares of the company’s stock worth $32,000 after purchasing an additional 77 shares during the last quarter. True Wealth Design LLC boosted its position in Elevance Health by 431.8% during the 3rd quarter. True Wealth Design LLC now owns 117 shares of the company’s stock valued at $38,000 after purchasing an additional 95 shares during the period. Finally, Glass Jacobson Investment Advisors llc grew its stake in Elevance Health by 400.0% during the 2nd quarter. Glass Jacobson Investment Advisors llc now owns 100 shares of the company’s stock worth $39,000 after buying an additional 80 shares during the last quarter. Institutional investors own 89.24% of the company’s stock.

Elevance Health Price Performance

NYSE ELV opened at $370.77 on Friday. Elevance Health, Inc. has a 12 month low of $273.71 and a 12 month high of $458.75. The firm has a market capitalization of $82.40 billion, a PE ratio of 15.16, a P/E/G ratio of 1.91 and a beta of 0.51. The company’s 50 day simple moving average is $349.17 and its 200 day simple moving average is $328.79. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.56 and a quick ratio of 1.56.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on ELV. Bank of America upped their price target on shares of Elevance Health from $330.00 to $370.00 and gave the stock a “neutral” rating in a research report on Friday, October 10th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $320.00 target price (down from $332.00) on shares of Elevance Health in a research note on Friday, December 19th. Mizuho set a $413.00 price target on shares of Elevance Health in a research note on Friday, January 9th. Guggenheim boosted their price objective on Elevance Health from $398.00 to $414.00 and gave the stock a “buy” rating in a research report on Thursday. Finally, Zacks Research upgraded Elevance Health from a “strong sell” rating to a “hold” rating in a research report on Thursday, November 6th. Twelve investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $399.63.

Elevance Health Company Profile

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.